Endoglin Controls Cell Migration and Composition of Focal Adhesions

Barbara A. Conley(National Cancer Institute), Calvin Vary(MaineHealth)

Journal of Biological Chemistry

June 1, 2004

10.1074/jbc.m312561200

Cited by 127

Related Papers

Effect of Capivasertib in Patients With an <i>AKT1 E17K</i>-Mutated Tumor

|JAMA Oncology|2020|106

Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck

|Cancer|2001|50

Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial

|npj Precision Oncology|2022|42

Phase II Study of Erdafitinib in Patients With Tumors With <i>FGFR</i> Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1

|JCO Precision Oncology|2024|16

Short‐term dietary methionine restriction with high fat diet counteracts metabolic dysfunction in male mice

|Physiological Reports|2025|3